Several Options for Frontline Treatment of MCL
/ Mats Jerkeman
The 2025 EHA Award Recipients
/ Amanda Feldballe Bernholm
EHA 2025: Nordic AML Group Explores Optimized Regimen for AML Patients
/ Anne Louise Tølbøll Sørensen
EHA 2025: Impact of Treating MRD Relapse Post 1L in Multiple Myeloma
/ Frida Bugge Askeland
Real-World Treatment Patterns of Nivolumab + Cabozantinib Compared with Other 1L IO Combinations in mRCC
/ Cherrishe Brown-Bickerstaff / Jan Andreasen
Cabozantinib Real-World Effectiveness in the Second-Line Setting of Metastatic Renal Cell Carcinoma
/ Martin Zarba / Jan Andreasen